234 results about "Curcuma" patented technology

The invention discloses a traditional Chinese medicine composition for treating skin diseases and a preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 6-12 parts of radix notoginseng, 8-15 parts of radix salviae miltiorrhizae, 10-20 parts of rhizoma chuanxiong, 8-15 parts of rhizoma curcumae longae, 15-35 parts of radix angelicae sinensis, 3-8 parts of sandalwood, 3-8 parts of fructus aurantii immaturus, 40-60 parts of ramulus cinnamomi, 8-15 parts of rhizoma corydalis, 8-15 parts of rhizoma curcumae, 2-5 parts of flos carthami, 5-12 parts of radix puerariae, 8-15 parts of radix rehmanniae, 3-8 parts of pericarpium citri reticulatae and 8-15 parts of spica prunellae. The traditional Chinese medicine composition is prepared from 3-8 parts of radix trichosanthis, 15-35 parts of tribulus terrestris, 15-35 parts of cicada slough, 5-12 parts of stiff silkworm and 8-15 parts of rhizoma drynariae. According to a multi-target collaborative mechanism, network pharmacology proves that 12 pathological pathways such as IL-17A and the like can be regulated and controlled, and the TNF-alpha inhibition rate is 89% and the barrier repair speed is increased by 2.3 times through key component combination. According to a transdermal synergistic technology, the specific surface area of the medicine reaches 8.5 m < 2 > / g through superfine grinding, a Franz test shows that the penetration amount of tanshinone is increased by 3.7 times, and the onset time is shortened to 8.3 minutes. Dual scar regulation and control: the thickness of scars in 12 weeks is reduced by half through TGF-beta3 up-regulation and alpha-SMA inhibition, and the collagen order degree is improved by 3.2 times.

The invention provides a traditional Chinese medicine composition for treating early primary Parkinson's disease and a preparation method thereof. The traditional Chinese medicine composition is prepared from the following components in parts by weight: 2-5 parts of radix astragali, 2-5 parts of radix asparagi, 4-6 parts of radix polygonati officinalis, 1-3 parts of fructus gardeniae, 1-3 parts of fermented soybean, 2-5 parts of fructus trichosanthis, 1-3 parts of radix curcumae, 2-5 parts of radix angelicae sinensis, 1-3 parts of rhizoma chuanxiong, 5-7 parts of radix paeoniae alba, 2-5 parts of caulis spatholobi, 1-3 parts of semen persicae, 1-3 parts of semen armeniacae amarae, 2-5 parts of fructus cannabis, 3-5 parts of radix asteris and 1-3 parts of radix platycodonis. And 15-20 parts by weight of an auxiliary material. The invention also provides a preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine composition provided by the invention can realize a treatment effect on the early primary Parkinson's disease.

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating lung cancer and a preparation method and application thereof. The traditional Chinese medicine composition is prepared from the following raw material medicines: lily, radix ophiopogonis, thunberg fritillary bulb, astragalus membranaceus, curcuma zedoary, lychee seed, poria cocos, radix scrophulariae, rhizoma anemarrhenae and loofah sponge. The traditional Chinese medicine composition has the effects of tonifying qi and yin, reducing phlegm and resolving masses, and is particularly suitable for treating a patient suffering from qi-yin deficiency and blood stasis type small cell lung cancer. The traditional Chinese medicine composition disclosed by the invention has the effects of reducing tumor cell proliferation, regulating tumor immunity, reducing toxicity and enhancing efficacy, and can also enhance the immunity of a patient, prolong the lifetime of the patient and improve the living quality of the patient.

The invention discloses a traditional Chinese medicine composition for reducing blood pressure and preventing heart diseases, and belongs to the technical field of traditional Chinese medicine preparation, and the traditional Chinese medicine composition is prepared from the following raw materials: selfheal, radix puerariae, eucommia ulmoides, salvia miltiorrhiza, ligusticum wallichii, radix paeoniae rubra, fructus trichosanthis, coptis chinensis, semen cassiae, angelica sinensis, radix paeoniae alba, rhizoma polygonati, dogwood, rhizoma atractylodis macrocephalae, poria cocos, radix cyathulae, radix curcumae, hawthorn and rheum officinale. The traditional Chinese medicine composition is suitable for people suffering from hypertension in the early stage, the middle stage and the later stage, has a good multi-target-point, targeted and broad-spectrum blood pressure lowering effect and a defecation effect, and can also protect the heart function, so that the risk of cardiovascular and cerebrovascular disease complications caused by hypertension lesion is reduced.

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating constipation and a preparation method and application thereof. The traditional Chinese medicine composition is prepared from betel nut, szechwan chinaberry fruit, bighead atractylodes rhizome, bunge cherry seed, vinegar-processed curcuma zedoary, immature bitter orange, officinal magnolia bark, coix seed and Chinese angelica. The traditional Chinese medicine composition disclosed by the invention has the effects of promoting qi circulation, removing stagnation, tonifying spleen, clearing damp, relaxing bowel, nourishing blood and promoting blood circulation, is mainly used for treating qi stagnation type, spleen deficiency type or mixed type constipation, and is particularly suitable for functional constipation, senile constipation or postpartum constipation with the syndromes. Besides, the traditional Chinese medicine composition is deeply optimized by utilizing a modern preparation process on the basis of a traditional Chinese medicine formula, the preparation method is simple, and the traditional Chinese medicine composition can be prepared into various dosage forms such as granules, tablets, oral liquid or capsules.

The invention provides a composition for assisting in protecting chemical liver injury as well as a preparation method and application thereof, and relates to the technical field of medicines. The composition for assisting in protecting the chemical liver injury comprises the following raw material components: radix puerariae, lucid ganoderma, hovenia dulcis thunb, schisandra chinensis, turmeric, Chinese yam, liquorice, Chinese dates, dandelion, chrysanthemum, radix polygonati officinalis and pericarpium citri reticulatae. The components are decocted and extracted with water, the extracting solutions are mixed and dried, and the obtained composition has the function of assisting in protecting chemical liver injury, is applied to products with the effects of improving damaged liver cells, reducing transaminase, reducing blood fat and improving the form of the liver and is remarkable in effect. The composition provided by the invention can effectively improve chemical liver injury of model mice within the dose range of each component, and has similar drug effects compared with a clinically applied drug silymarin.

The present invention relates to a product containing elderberry extract and a potentiator selected from pepper extract, ginger extract, curcuma extract and citrus plant extract.

The invention discloses a formula for reducing phlegm and resolving masses, and a preparation method and application of freeze-dried powder of the formula for reducing phlegm and resolving masses, and belongs to the technical field of traditional Chinese medicines. The traditional Chinese medicine composition inhibits triple negative breast cancer adhesion-metastasis by regulating an FAK / SRC pathway, and comprises the following components by weight: 10-20 g of poria cocos, 10-20 g of rhizoma bolbostemmae, 10-20 g of radix trichosanthis, 5-12 g of curcuma zedoary, 10-20 g of selfheal, 10-20 g of oyster (smashed and decocted first), and 5-12 g of uniflower swisscentaury root. In-vitro experiments show that HTSJF can inhibit TNBC cell invasion, migration and adhesion (P is less than 0.01) in a dose-dependent manner, and along with reduction of the phosphorylation level of an FAK / SRC pathway, it is prompted that HTSJF inhibits TNBC transfer by regulating the pathway. In-vivo experiments prove that the HTSJF can obviously inhibit the reduction of TNBC pulmonary metastasis focus (P is less than 0.05) and recover part of normal pulmonary alveolar structures, and the inhibition effect of the HTSJF on TNBC pulmonary metastasis is further proved.

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition with an effect of preventing and treating alcoholic liver injury as well as a preparation method and application thereof. The traditional Chinese medicine composition is prepared from the following raw material medicines: radix puerariae, turmeric, ginseng, hovenia dulcis thunb, white hyacinth bean, raw oyster shell, poria cocos, raw hawthorn, biond magnolia flower, juncus effuses and albizia flower. The traditional Chinese medicine composition has the effects of soothing liver and harmonizing stomach, dispelling alcohol effect and enlivening spleen, and reinforcing qi and nourishing blood. Experimental results show that the traditional Chinese medicine composition has a good treatment effect on acute alcoholic liver injury and chronic alcoholic fatty liver, and can effectively improve the symptoms of chest rib swelling pain, reduced appetite, anorexia, abdominal distension, hiccup, belching, borborygmus and qi and loose stool caused by liver-stomach disharmony and spleen deficiency and dampness of alcoholic liver injury patients; therefore, the method has good development and utilization prospects.

The invention discloses a Chinese herbal medicine composition, a preparation method and application of the Chinese herbal medicine composition in freckle-removing and whitening products. The Chinese herbal medicine composition comprises the following raw materials in parts by weight: 45-60 parts of lonicerae flos / dogwood leavening, 20-35 parts of bletilla striata extract and 20-35 parts of curcuma zedoary extract. Wherein the lonicerae flos / dogwood leavening is obtained by activating bifidobacteria, inoculating the bifidobacteria into a seed culture medium, culturing to obtain a seed solution, then transferring the seed solution into a fermentation culture medium, culturing to obtain a fermentation solution, and finally filtering and freeze-drying the fermentation solution; wherein the seed culture medium contains a dogwood extract, and the fermentation culture medium contains a lonicerae flos extract and a dogwood extract. All the components in the Chinese herbal medicine composition have a synergistic effect, and the Chinese herbal medicine composition has the remarkable effects of resisting oxidation, inhibiting tyrosine, repairing ultraviolet aging skin and the like.

This invention relates to the field of traditional Chinese medicine preparation technology, and discloses a Qingfu Chaijin granule, its preparation method, and its application. The Qingfu Chaijin granule comprises the following traditional Chinese medicine raw materials in parts by weight: Bupleurum chinense 8-12 parts, Cyperus rotundus 8-12 parts, Citrus reticulata peel 8-12 parts, Salvia miltiorrhiza 12-18 parts, Curcuma longa 8-12 parts, Angelica sinensis 8-12 parts, Ligusticum chuanxiong 5-8 parts, Foeniculum vulgare 8-12 parts, Amethyst 25-35 parts, Artemisia argyi 5-8 parts, Cistanche deserticola 8-12 parts, Epimedium brevicornu 8-12 parts, and Rehmannia glutinosa 8-12 parts. The invention also discloses the application of the aforementioned Qingfuchaijin granules in the preparation of drugs for relieving or treating dysmenorrhea caused by qi stagnation and blood stasis. By scientifically optimizing the compatibility ratio of Qingfuchaijin granules and combining it with a reasonable preparation process design, the resulting Qingfuchaijin granules have been significantly improved in terms of stability, user experience, and performance. The use of dry granulation or spray drying-dry granulation combined technology effectively reduces the initial moisture content of the granules, significantly reduces the hygroscopicity of the granules, and improves the storage stability of the product.

The present application relates to the technical fields of natural product extraction and biomimetic preparation, and provides a method for extracting curcuma oil body from fresh turmeric, curcuma oil body microcapsules and application thereof.The method comprises the following steps: S11, adding the pretreated fresh turmeric into an extraction solution and shearing and crushing; S21, adjusting the pH of the extraction solution, adding a composite enzyme system, and then performing ultrasonic enzymolysis; S31, adjusting the pH of the enzymolysis solution, and then performing inactivation and filtration to obtain a first filtrate and a filter residue; S41, adding a density gradient medium to the first filtrate, and then performing low-temperature centrifugal separation to collect the upper cream to resuspend and obtain an initial emulsion containing curcuma oil body; S51, adding a surfactant to the initial emulsion, adjusting the pH, and then filtering to obtain a second filtrate; S61, centrifuging the second filtrate at low temperature, collecting the upper cream to resuspend and obtaining curcuma oil body emulsion.The curcuma oil body obtained by the present application has the advantages of high solubility, high stability and high bioavailability.

The invention provides a traditional Chinese medicine preparation for improving or treating cognitive impairment, and relates to the technical field of traditional Chinese medicine pharmacy, and the traditional Chinese medicine preparation is prepared from morinda officinalis, eclipta, semen boitae, fructus alpiniae oxyphyllae, bighead atractylodes rhizome, valerian, turmeric, rhizoma acori graminei, leech, rhizoma anemarrhenae, dendrobium officinale, endothelium corneum gigeriae galli, hematoxylon and honey-fried licorice root. The traditional Chinese medicine preparation shows remarkable neuroprotection and cognition improvement effects on the cell level and the animal level, in the cell level, the preparation can effectively resist Abeta1-42 induced cell damage, and the protection effect is achieved through multiple ways of improving the cell activity, enhancing the oxidation resistance, inhibiting neuroinflammation and the like; in animal experiments, the preparation can comprehensively improve cognitive impairment of APP / PS1 model mice, including relieving behavioral abnormality, improving spatial learning and memory ability, enhancing new object recognition ability, and effectively reducing deposition of A beta in hippocampus on a molecular level. The invention provides a new thought for improving or treating cognitive impairment.

The present application relates to a kind of anti-non-small cell lung cancer for strengthening healthy qi and resolving stasis and preparation method thereof, strengthening healthy qi and resolving stasis is made from the following weight proportion of raw medicinal materials: Ficus pumila 2g~50g / portion, radix pseudostellariae 2g~50g / portion, poria cocos 2g~50g / portion, atractylodes 2g~50g / portion, radix scutellariae 2g~50g / portion, oldenlandia 2g~50g / portion, cat's paw grass 2g~50g / portion, giant knotweed 2g~50g / portion, curcuma zedoary 2g~50g / portion, oyster 2g~50g / portion, platycodon 2g~50g / portion, mountain bitterling 2g~50g / portion, half branch orchid 2g~50g / portion. By cell test and the construction NSCLC osimertin drug resistance animal model prove, strengthening healthy qi and resolving stasis of the present application can adjust tumor microenvironment (TME) and inhibit non-small cell lung cancer cell growth of osimertin drug resistance. Not only this, strengthening healthy qi and resolving stasis of the present application can also inhibit common non-small cell lung cancer cell growth. While clinical observation finds, strengthening healthy qi and resolving stasis of the present application can improve insomnia, skin rash, diarrhea and other symptoms of lung accumulation (lung cancer, lung nodule) patient, improve its quality of life.

Compositions and methods are disclosed for treating one or more symptoms of perimenopause. A composition includes a cannabidiol, a Curcuma longa extract, and / or a Lepidium meyenii extract. A method of manufacturing a composition comprises including a cannabidiol, a Curcuma longa extract, and / or a Lepidium meyenii extract in the composition. A method of administering a composition includes administering a cannabidiol, a Curcuma longa extract, and / or a Lepidium meyenii extract of the composition.

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating chronic atrophic gastritis and a preparation method of the traditional Chinese medicine composition. Comprising the following raw materials: 2-30 parts of astragalus membranaceus, 2-30 parts of bighead atractylodes rhizome, 1-30 parts of codonopsis pilosula, 1-30 parts of poria cocos, 1-30 parts of Chinese yam, 1-40 parts of salvia miltiorrhiza, 2-30 parts of rhizoma sparganii, 1-40 parts of curcuma zedoary, 1-20 parts of elecampane, 1-20 parts of fructus amomi, 2-30 parts of pericarpium citri reticulatae, 1-30 parts of rhizoma pinellinae praeparata, 1-30 parts of dried ginger, 5-20 parts of coptis chinensis, 1-30 parts of immature bitter orange, 3-30 parts of endothelium corneum gigeriae galli and 2-30 parts of raw liquorice. The traditional Chinese medicine composition disclosed by the invention can be used for effectively treating clinical symptoms of CAG, reversing atrophy, intestinal metaplasia and dysplasia of mucosa, remarkably improving endoscopic manifestation of a CAG patient and promoting lesion of gastric mucosa to be relieved or disappear. Animal experiments show that the traditional Chinese medicine can reduce and reverse lesions such as gastric mucosa gland atrophy and epithelium intestinal metaplasia of CAG rats. Mitochondrial metabolic disorder is a key link of CAG gland atrophy and can effectively block CAG canceration.

This invention relates to the field of traditional Chinese medicine (TCM) technology. The invention provides a TCM composition for treating glaucoma and its preparation method, comprising the following components in parts by weight: 18-28 parts of Cassia seed, 12-18 parts of Lycium fruit, 12-18 parts of Eriocaulon buergerianum, 10-15 parts of vinegar-processed Cyperus rotundus, 10-15 parts of mulberry leaf, 10-15 parts of Ligusticum chuanxiong, 8-12 parts of Polyporus umbellatus, 5-8 parts of Pueraria lobata, 5-8 parts of Akebia quinata, 3-5 parts of Curcuma longa, 3-5 parts of Indigo naturalis, and 2-4 parts of prepared licorice root. The TCM composition of this invention has a strong effect in lowering intraocular pressure, improving retinal blood supply, and preventing optic nerve atrophy caused by glaucoma; simultaneously, the processing method maximizes the retention of the active pharmaceutical ingredients. Furthermore, the technical solution of this invention achieves a dual improvement in efficacy and safety, and also reduces the recurrence rate and side effects.

The invention relates to a body resistance strengthening and stagnation eliminating prescription for resisting non-small cell lung cancer and a preparation method thereof. The body resistance strengthening and stagnation eliminating prescription is prepared from the following raw material medicines in parts by weight: 2-50g / part of radix fici simplicissimae, 2-50g / part of radix pseudostellariae, 2-50g / part of poria cocos, 2-50g / part of rhizoma atractylodis macrocephalae, 2-50g / part of radix scutellariae, 2-50g / part of oldenlandia diffusa, 2-50g / part of radix ranunculi ternati, 2-50g / part of polygonum cuspidatum, 2-50g / part of curcuma zedoary, 2-50g / part of oyster, 2-50g / part of platycodon grandiflorum, 2-50g / part of edible tulip and 2-50g / part of sculellaria barbata. Cell tests and construction of an NSCLC osimertinib-resistant animal model prove that the body resistance strengthening and stagnation eliminating prescription can regulate a tumor microenvironment (TME) and inhibit growth of osimertinib-resistant non-small cell lung cancer cells. In addition, the formula for strengthening the body resistance and removing stasis can also inhibit growth of common non-small cell lung cancer cells. Meanwhile, clinical observation finds that the body resistance strengthening and stasis removing prescription can improve symptoms such as insomnia, rash and diarrhea of patients with lung accumulation (lung cancer and pulmonary nodule), and improve the life quality of the patients.

The invention relates to the technical field of traditional Chinese medicine compositions, and particularly discloses a Miao medicine traumatology liquid for relieving swelling and pain of fracture and a preparation method thereof.The Miao medicine traumatology liquid is prepared from, by weight, 10-20 parts of callicarpa macrophylla, 10-20 parts of sargentgloryvine stem, 15-20 parts of honeysuckle, 10-15 parts of polygonum cuspidatum, 10-15 parts of golden cypress and 15-20 parts of radix rubiae. , 10-15 parts of turmeric, 10-20 parts of motherwort, 6-8 parts of frankincense, 6-8 parts of myrrh and 10-15 parts of cape jasmine. In the Miao medicine traumatology liquid provided by the invention, the callicarpa macrophylla can dissipate blood stasis, stop bleeding and relieve swelling and pain, the polygonum cuspidatum can clear away heat and toxic materials, dissipate blood stasis and relieve pain, and the motherwort can clear away heat and toxic materials, activate blood and relieve swelling; lonicera japonica, golden cypress and cape jasmine have the effects of clearing away heat and toxic materials, purging fire and relieving pain, and serve as ministerial drugs together. Turmeric, frankincense and myrrh are used for removing blood stasis, promoting the circulation of qi and relieving swelling and pain, and are used as adjuvant drugs together; the traditional Chinese medicine composition has the remarkable effects of promoting blood circulation to remove blood stasis and relieving swelling and pain on the fracture part of a patient through combined use of all the medicines and simultaneous application of blood circulation and heat clearing.

The invention relates to the technical field of traditional Chinese medicine compositions, and particularly discloses a composition for treating ejection fraction retention heart failure, which is technically characterized by comprising the following components in parts by weight: 8-10 parts of ginseng, 15-20 parts of salvia miltiorrhiza, 10-12 parts of radix polygonati officinalis, 10-15 parts of rhodiola rosea, 5-10 parts of pseudo-ginseng, 10-15 parts of turmeric, 15-17 parts of bighead atractylodes rhizome, 15-17 parts of poria cocos and 10-12 parts of centella asiatica. , 10-12 parts of herba lycopi and 10-12 parts of semen lepidii. Through systematic clinical observation and practice, the composition provided by the invention can obviously improve the clinical curative effect of a patient, improve traditional Chinese medicine syndromes, diastolic function indexes and exercise tolerance, and improve life quality; and the kit has a positive clinical application value for patients with clear diagnosis, accurate syndrome differentiation and good indication mastering.

The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating interstitial lung disease with fibrosis and a preparation method and application thereof.The traditional Chinese medicine composition is prepared from, by weight, 5-15 parts of ginseng, 8-15 parts of radix asparagi, 10-20 parts of radix rehmanniae recen, 15-25 parts of astragalus membranaceus, 5-15 parts of schisandra chinensis, 15-25 parts of honey-fried radix asteris, 15-25 parts of honey-fried flos farfarae, 8-15 parts of curcuma zedoary, 8-15 parts of peach kernels and 8-15 parts of herba epimedii. , 15-30 parts of semen lepidii, 10-20 parts of fructus liquidambaris, and 10-20 parts of semen sinapis. The traditional Chinese medicine composition provided by the invention has the effects of strengthening vitality, reducing phlegm, activating blood, removing blood stasis and dredging collaterals, and can improve clinical symptoms of patients with interstitial lung diseases and fibrosis, improve life quality and delay disease progression.

The invention relates to an automatic preparation method and device of a medicament for treating liver cirrhosis. A traditional Chinese medicine decoction is prepared from the following raw materials in parts by weight: 10 parts of radix astragali, 5 parts of radix notoginseng, 15 parts of radix salviae miltiorrhizae, 10 parts of rhizoma atractylodis macrocephalae stir-fried with bran, 10 parts of poria cocos, 10 parts of fructus aurantii stir-fried with bran, 15 parts of vinegar turtle shell, 5 parts of vinegar schisandra chinensis, 15 parts of vinegar tortoise shell, 10 parts of peach kernel, 10 parts of radix curcumae, 15 parts of Chinese lobelia and 20 parts of phyllanthus urinaria. An automatic preparation device of the liver cirrhosis treatment medicament is applied, and the method comprises the following steps: S1, filling; s2, performing soaking; s3, decocting first; s4, group decoction; s5, later operation is carried out; s6, squeezing; a standardized decoction process aiming at a specific liver cirrhosis treatment prescription can be executed in a single container through exquisite mechanical linkage and automatic control in a whole process without manual intervention, and a specific traditional Chinese medicine formula (astragalus membranaceus, vinegar turtle shell and the like) is deeply combined with an automatic operation process of the device, so that a set of optimized preparation process is formed.

The invention discloses a traditional Chinese medicine composition for treating obesity phlegm-dampness obstructing spleen syndrome. Comprising the following raw material medicines in parts by weight: 18-25 parts of astragalus membranaceus, 11-15 parts of bighead atractylodes rhizome (fried), 11-15 parts of poria cocos, 8-12 parts of rhizoma alismatis, 3-5 parts of coptis chinensis (fried with wine), 4-6 parts of rheum officinale (fried with wine), 8-12 parts of semen cassiae (fried), 7-12 parts of radix bupleuri (fried with vinegar), 11-15 parts of hyperforin perforatum, 13-18 parts of oriental wormwood, 10-15 parts of salvia miltiorrhiza (fried with wine), 7-9 parts of curcuma zedoary (fried with vinegar), 7-10 parts of polygonum cuspidatum, 14-20 parts of herba epimedii (fried), 6-8 parts of rhizoma zingiberis and 10-15 parts of glossy privet fruit (steamed with wine). The traditional Chinese medicine composition is prepared from 14-20 parts of prepared rehmannia roots, 18-25 parts of hawthorn fruits, 10-15 parts of lotus leaves, 8-12 parts of mulberry twigs, 7-9 parts of baikal skullcap roots (roasted with wine), 8-12 parts of polygala roots, 10-15 parts of kudzuvine roots and 7-9 parts of licorice roots (roasted). The traditional Chinese medicine composition is researched and developed on the basis of complex pathogenesis and pathogenesis of the obesity phlegm-dampness obstructing spleen syndrome, and has an expected effect of treating the obesity phlegm-dampness obstructing spleen syndrome.

The invention relates to an Angong bezoar pill and a preparation method thereof. The Angong bezoar pill contains 0.2 part of a bionic rhinoceros horn biological agent, 0.1 part of the bionic rhinoceros horn biological agent, 0.025 part of musk, 0.05 part of pearl, 0.1 part of cinnabar, 0.1 part of realgar, 0.1 part of coptis chinensis, 0.1 part of scutellaria baicalensis, 0.1 part of cape jasmine, 0.1 part of radix curcumae and 0.025 part of borneol for compatible use. The similarity between the core chemical components of the bionic rhinoceros horn biological agent and the natural rhinoceros horn reaches 95% or above, and the composition and content of active substances meet the drug effect requirements.

The invention provides a traditional Chinese medicine composition for treating pulmonary nodules and a preparation method thereof. The traditional Chinese medicine composition is prepared by extracting the following traditional Chinese medicine decoction pieces in parts by weight: 25-35 parts of raw coix seeds, 8-12 parts of platycodon grandiflorum, 8-12 parts of curcuma zedoary, 8-12 parts of radix curcumae, 8-12 parts of salvia chinensis, 8-12 parts of astragalus membranaceus, 8-12 parts of radix pseudostellariae, 8-12 parts of akebia fruits, 10-20 parts of oldenlandia diffusa, 10-20 parts of rabdosia rubescens, 3-7 parts of radix ranunculi ternati and 8-12 parts of glossy privet fruits. The traditional Chinese medicine can be used for treating the phlegm stasis and toxin stagnation syndrome type pulmonary nodule, and fully embodies the treatment principle of clearing damp and reducing phlegm, promoting blood circulation to remove blood stasis, promoting qi circulation to relieve pain, tonifying qi and lifting yang, replenishing qi and strengthening spleen, promoting salivation and moistening lung, promoting qi circulation to diuresis, promoting qi circulation to relieve pain, strengthening spleen to promote digestion, clearing away heat and toxic materials, promoting diuresis and eliminating carbuncle, promoting blood circulation to relieve pain, nourishing liver and kidney, and preventing blood-activating drugs from consuming blood and injuring yin; the traditional Chinese medicine is an effective prescription for treating the phlegm stasis and toxin stagnation syndrome type pulmonary nodule.

The invention discloses a traditional Chinese medicine for treating haemorrhoids, which comprises the following raw materials: borneol, centipeda minima, pepper, radix sophorae flavescentis, seaweed, rheum officinale, radix curcumae, radix angelicae, perilla leaf, mint, prepared myrrh and realgar. The composition design, pathogenesis and pathology distinguishing and channel tropism logic are strict and reasonable, and the effects of relieving pain and stopping bleeding, softening hardness to dissipate stagnation, removing slough and promoting tissue regeneration and treating both symptoms and root causes can be achieved when hemorrhoids are treated. The traditional Chinese medicine composition has the advantages of simple preparation process, quick effect of relieving pain and stopping bleeding and short curing time, can be used for treating hemorrhoids at different disease positions such as internal hemorrhoids, external hemorrhoids and mixed hemorrhoids, and can also be used for treating constipation, rectocele, anal abscess, rectal cancer, anal eczema and other related anorectal diseases.

This invention provides a traditional Chinese medicine preparation for promoting blood circulation and relieving pain, and its preparation method, relating to the field of traditional Chinese medicine pharmaceutical technology. The preparation is made from the following parts by weight of traditional Chinese medicine raw materials: 10-30 parts of Polygonatum sibiricum, 10-30 parts of Spatholobus suberectus, 10-30 parts of Curcuma longa, 5-20 parts of Sparganium stoloniferum, 5-20 parts of Areca catechu peel, 5-20 parts of Polygonum hydropiper, 5-20 parts of Rhizoma Scutellariae, 1-5 parts of Artemisia argyi, 5-20 parts of Solanum nigrum, 5-20 parts of Catechu, 10-30 parts of Scutellaria barbata, 5-20 parts of Aristolochia debilis, 10-30 parts of Astragalus membranaceus, and 5-20 parts of Artemisia argyi oil. The traditional Chinese medicine preparations described in this invention differ from those that typically enhance the efficacy of a single herb. Instead, they exhibit a synergistic relationship where one plus one equals more than two. The principal, assistant, adjuvant, and guide herbs complement each other, combining both tonifying and purging effects. This approach effectively promotes the dissipation of blood stasis, unblocks the flow of qi and blood in the meridians, eliminates local inflammation, and reduces swelling and pain. Simultaneously, it nourishes the tendons and bones, supports the body's vital energy, and enhances the body's ability to resist pathogens and repair damage. Thus, it comprehensively alleviates pain caused by various factors, achieving the goals of promoting blood circulation, removing blood stasis, clearing the meridians, reducing inflammation and swelling, and relieving pain.

The present invention discloses an intelligent perception and adaptive control system for Curcuma longifolia processing equipment, comprising: a data perception module for real-time monitoring of processing parameters based on a dynamic data acquisition model; eliminating data noise through data filtering and calibration formulas; a processing parameter optimization module for assessing processing quality based on a processing quality evaluation model; and optimizing parameters under constraints using optimization targets; a dynamic adaptive control module for generating control signals using a PID control algorithm; and a parameter adjustment module for updating processing parameters based on a dynamic processing parameter adjustment formula. The present invention has the following beneficial effects: achieving high-precision perception, real-time monitoring, and intelligent adjustment of the processing environment and processing parameters, thereby improving processing quality stability and production efficiency.

The invention provides a traditional Chinese medicine composition for treating vascular cognitive impairment. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 24-36 parts of prepared rehmannia root, 12-18 parts of rhizoma polygonati, 4.8-7.2 parts of prepared fleece flower root, 12-18 parts of ligusticum wallichii, 8-12 parts of polygala tenuifolia, 12-18 parts of herba epimedii, 25 parts of dendrobe, 12-18 parts of poria cocos, 12-18 parts of thunberg fritillary bulb, 12-18 parts of rhizoma acori graminei, 10 parts of radix ophiopogonis, 20 parts of radix curcumae, 8-12 parts of cinnamon, 4.8-7.2 parts of black prepared aconite root and 0.24-0.36 part of borneol. The invention provides a preparation method and application of the traditional Chinese medicine composition. The medicine disclosed by the invention is used for treating the vascular cognitive impairment, especially for treating the vascular cognitive impairment with the syndrome of kidney deficiency and phlegm stasis, and the medicine effect is definite.

Antimicrobial compositions and methods for making and using the same are disclosed. The compositions comprise an effective amount of one or more of a Cryptolepis sanguinolenta tincture, a Sida acuta tincture, a Terminalia chebula tincture, an Alchornea cordifolia tincture, a Phyllanthus emblica tincture, a Curcuma longa tincture, an Olea europaea tincture, an Embelia ribes tincture, a Tinospora cordifolia tincture, and an Ocimum tenuiflorum tincture.